Luke Nathaniel Walker - 24 Jan 2023 Form 4 Insider Report for Harpoon Therapeutics, Inc.

Role
Chief Medical Officer
Signature
/s/ Frank Lanza, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
24 Jan 2023
Net transactions value
$0
Form type
4
Filing time
26 Jan 2023, 15:05:55 UTC
Previous filing
04 Oct 2022
Next filing
28 Nov 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HARP Employee Stock Option (right to buy) Award $0 +100,000 $0.000000 100,000 24 Jan 2023 Common Stock 100,000 $0.8900 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the total stock option will vest and become exercisable every six months following the vesting commencement date of January 24, 2023, subject to the continuing employment of the Reporting Person on each vesting date.